LENSAR, Inc. Common Stock LNSR

$6.37 -1.24% at last close
Market Cap$79.24 million
P/E Ratio—
Div Yield—
Volume15.3K
52-Week Range $4.95$12.94

Analyst Ratings

Consensus
Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
Avg. Price Target
$10.50 (+64.8% upside)

Full LNSR forecast & analyst actions →

Key Stats

Today's Range
$6.37 – $6.54
50-Day Range
$4.95 – $9.25
52-Week Range
$4.95 – $12.94
Volume
15K shs
Average Volume
62K shs
Market Cap
$79.24 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
5.49%
Days to Cover
3.23

About LENSAR, Inc. Common Stock

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
150
Exchange
XNAS
Listed
2020-09-21

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.